Cargando…
PHARMACOVIGILANCE: SCOPE FOR A DERMATOLOGIST
Pharmacovigilance is defined as the science of detection, assessment, and prevention of adverse drug reactions in humans. Under-reporting of drug reactions is the major problem and has various reasons. The WHO has initiated the program of reporting all adverse drug reactions now co-ordinated by the...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221205/ https://www.ncbi.nlm.nih.gov/pubmed/22121260 http://dx.doi.org/10.4103/0019-5154.87121 |
_version_ | 1782217058411347968 |
---|---|
author | Prakash, Bhanu Singh, Gurcharan |
author_facet | Prakash, Bhanu Singh, Gurcharan |
author_sort | Prakash, Bhanu |
collection | PubMed |
description | Pharmacovigilance is defined as the science of detection, assessment, and prevention of adverse drug reactions in humans. Under-reporting of drug reactions is the major problem and has various reasons. The WHO has initiated the program of reporting all adverse drug reactions now co-ordinated by the Uppsala Monitoring Centre in Uppsala, Sweden, with oversight by an international board. This article presents in brief the relevance, functioning, importance, and the procedure of reporting adverse drug reactions. Dermatologists have the greatest opportunity in reporting various reactions that can happen as they come across majority of these drug reactions, prescribed by all sectors of the health system. |
format | Online Article Text |
id | pubmed-3221205 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-32212052011-11-25 PHARMACOVIGILANCE: SCOPE FOR A DERMATOLOGIST Prakash, Bhanu Singh, Gurcharan Indian J Dermatol Special Article Pharmacovigilance is defined as the science of detection, assessment, and prevention of adverse drug reactions in humans. Under-reporting of drug reactions is the major problem and has various reasons. The WHO has initiated the program of reporting all adverse drug reactions now co-ordinated by the Uppsala Monitoring Centre in Uppsala, Sweden, with oversight by an international board. This article presents in brief the relevance, functioning, importance, and the procedure of reporting adverse drug reactions. Dermatologists have the greatest opportunity in reporting various reactions that can happen as they come across majority of these drug reactions, prescribed by all sectors of the health system. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3221205/ /pubmed/22121260 http://dx.doi.org/10.4103/0019-5154.87121 Text en Copyright: © Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Special Article Prakash, Bhanu Singh, Gurcharan PHARMACOVIGILANCE: SCOPE FOR A DERMATOLOGIST |
title | PHARMACOVIGILANCE: SCOPE FOR A DERMATOLOGIST |
title_full | PHARMACOVIGILANCE: SCOPE FOR A DERMATOLOGIST |
title_fullStr | PHARMACOVIGILANCE: SCOPE FOR A DERMATOLOGIST |
title_full_unstemmed | PHARMACOVIGILANCE: SCOPE FOR A DERMATOLOGIST |
title_short | PHARMACOVIGILANCE: SCOPE FOR A DERMATOLOGIST |
title_sort | pharmacovigilance: scope for a dermatologist |
topic | Special Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221205/ https://www.ncbi.nlm.nih.gov/pubmed/22121260 http://dx.doi.org/10.4103/0019-5154.87121 |
work_keys_str_mv | AT prakashbhanu pharmacovigilancescopeforadermatologist AT singhgurcharan pharmacovigilancescopeforadermatologist |